Dennis D. Kim, Chief Medical Officer at CymaBay Therapeutics, Inc. (CBAY), bought 20,000 shares at $3.04 ($61K) on 2022-01-19, disclosed to the SEC on 2022-01-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZFGN | BUY | 2017-07-12 | $34K | — | Filing → |
| ZFGN | BUY | 2017-05-11 | $44K | — | Filing → |
| ZFGN | SELL | 2015-09-17 | $1.6M | — | Filing → |